Xgeva 120 MG/1.7 ML vial 1.7ML
Ended Awarded
- Contract number
- SPE2DB25FKLNH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,865
Award facts
- Contract value 100% obligated
- $18,865.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,865.07 to AmerisourceBergen Drug Corp for the supply of XGEVA 120 mg/1.7 mL vials on June 17, 2025, with an ultimate completion date of June 18, 2025. This firm fixed-price, non-set-aside delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total contract value of $999,999,999.00 through December 2026. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania.
As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen leverages its comprehensive IDC with the DLA to provide pharmaceutical products and medical supplies to military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. XGEVA (denosumab) is a specialty pharmaceutical product used in oncology and bone health treatment. This delivery order represents a routine transaction within AmerisourceBergen's extensive portfolio of competitively awarded contracts with the DLA, reflecting the company's established capability to fulfill federal pharmaceutical supply requirements at both high and low transaction values.
Quick answers
Who was awarded contract SPE2DB25FKLNH?
SPE2DB25FKLNH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 17, 2025.
How much is contract SPE2DB25FKLNH worth?
The government has obligated $18,865 on SPE2DB25FKLNH.
Is contract SPE2DB25FKLNH an order under another contract?
Yes. SPE2DB25FKLNH is a delivery order under SPE2DB24D2101, an indefinite delivery contract.
Was contract SPE2DB25FKLNH competed?
The extent of competition for SPE2DB25FKLNH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award